Encourages Satiety - GLP-1 support helps reduce appetite for weight management
In the EPIC Study, the investigators express no surprise at all about the sudden deaths, and they counted the pre-CHF sudden deaths as only a meaningless, insignificant statistic
Here, we will discuss the common side effects, how often they occur, their severity, and how to manage them
A hiatus hernia increases reflux susceptibility, but tirzepatide is not contraindicated
Clinical trials demonstrate that patients lose an average of 15-22% of body weight over 68 weeks, but the timeline for initial results varies based on dose escalation, metabolism, and individual genetic factors
Liragultide is easy to access and is usually covered by most insurance plans